Ion Channels
|
Westaway, et al. 2011179
|
CASQ2 GPD1L |
29-45% |
Americans of European ancestry, general population |
670/299 |
Polymorphisms in these genes are associated with SCD. |
Albert, et al. 2010188
|
KCNQ1 KCNH2 SCN5A KCNE1 KCNE2 |
60-70% |
Americans of European ancestry, general population |
516/1522 |
2 intronic variants (1 in KCNQ1 and 1 in SCN5A) were associated with SCD. |
Stecker, et al. 2006189
|
SCN5A |
1-4%* |
Americans of European ancestry with coronary disease |
67/91 |
No association was observed between SCN5A polymorphisms or mutations with SCD. |
Burke, et al. 2005190
|
SCN5A (Y1102A) |
9% |
African American, general population |
182/107 |
Y1102A was associated with unexplained arrhythmic death and with SCA with ventricular hypertrophy compared with non-cardiac deaths. |
Splawski, et al. 2002191
|
SCN5A (Y1102A) |
13% |
African American, general population |
23/100 |
Variant is associated with an increased risk of SCD or medication induced QTc prolongation. |
|
Autonomic Nervous System
|
Gavin, et al. 2011192
|
β2AR (Gln27Glu) |
40-60% |
Americans of European ancestry, general population |
492/1388 |
When combined with the 2 analyses below, the β2AR polymorphism is associated with SCD. |
Tseng, et al. 2008193
|
β2AR and β1AR
|
30-40% |
Aborted SCD and history of MI/CAD, 75% Americans of European ancestry |
107/388 |
No association was observed between any of the variants and SCD. |
Sotoodehnia, et al. 2006194
|
β2AR (Gln27Glu) |
57% whites, 81% African Americans |
American cohort (4441 European ancestry, 808 African Americans) |
195/5249 |
The β2AR variant is associated with SCD in whites but not blacks. |
Snapir, et al. 2003195
|
Alpha2B-AR |
51% |
Finnish, population based |
278/405 |
The deletion/deletion genotype of the alpha2B-adrenoceptor gene increased the risk for SCD in middle-aged men. |
|
Thrombotic and Atherogenic Factors
|
Hernesniemi, et al. 2008196
|
IL-18 |
40% |
Finnish, population based |
275/388 |
The IL-18 polymorphism is associated with SCD. |
Mikkelsson, et al. 2002197
|
GPIa |
50-60% |
Finnish, population based |
275/369 |
Polymorphisms on the glycoprotein Ia receptor are not associated with SCD. |
Reiner, et al. 2002198
|
Factor V Leiden and PT 20210A
|
6-9% |
American cohort (93% European ancestry) |
145/592 |
Mutations in these genes are not associated with SCD. |
Mikkelsson, et al. 2001199
|
GPIbα |
23% |
Finnish |
196/289 |
The variant was associated with coronary thrombosis, fatal MI and SCD in middle age men. |
Mikkelsson, et al. 2000200
|
GPIIIa |
30-40% |
Finnish, population based |
281/385 |
The PlA1/A2 polymorphism of GPIIIa is a risk factor for coronary thrombosis and SCD in middle age. |
|
Angiotensin-Converting Enzyme Pathway
|
Sotoodehnia, et al. 2009201
|
REN |
15% |
Americans of European ancestry, population based |
211/730 |
Variations in AGTR1 and AGTR2 are associated with SCA risk in a population-based case-control study. |
AGTR1 |
AGTR2 |
ACE2 |
BDRK2 |
AGT |
ACE |
KNG1 |